| 摘要 |
<p>Use of CASB933 polypeptides and polynucleotides in diagnostics, immunogenic compositions and vaccines, for prophylactic and therapeutic treatment of cancers, particularly prenoeplasic lesions of lung cancer, for instance small cell lung cancer (SCLC), or non small cell lung cancer (NSCLC) such as squamous (epidermoid) carcinoma, adenocarcinoma (including bronchoalveolar) and large cell (undifferentiated) carcinoma, or carcinoids, or bronchial gland tumours or mesotheliomas, even more particularly NSCLC preneoplasic lesions and early stage (classification stages 0, or IA, or IB, or IIA, or IIB of Mountains's staging) NSCLC.</p> |
